MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC.   Report issue

For profit Phase 4
Founded: Montreal Canada (1978)

Organization Overview

First Clinical Trial
2017
NCT03150537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC.

Active Ingredients

Drugs in Phase 4 Trials (1)

inactivated influenza vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1